Dr. Oliviero Gobbo (firstname.lastname@example.org)
Dr. Oliviero Gobbo is a Senior Research Fellow with 10 years’ experience in clinical and pre-clinical MRI. This expertise has leaded him to become involved in different EU projects related to nanomedicine such as ‘Multifun’, “EUNCL’ and ‘NoCanTher’. Dr Oliviero Gobbo is currently working within the drug delivery area in the School of Pharmacy and Pharmaceutical Sciences, Trinity College Dublin. He has a particular interest in the improvement of drug delivery, peptide delivery and gene delivery, via different nanocarriers (including e.g. liposomes, nanoparticles, SPION, nanoporous macroparticules). Trained in pre-clinical pharmacokinetics and toxicology, he has been working in private industries and academia for over 20 years. Dr. Gobbo is member of the Magnetic Resonance Imaging (MRI) committee, the Animal Research Ethics committee (Trinity College Dublin), serves as a delegate onto the Management Committee for COST Action TD1402 (Multifunctional Nanoparticles for Magnetic Hyperthermia and Indirect Radiation Therapy) and COST action CA17140 (Cancer nanomedicine – from the bench to the bedside). As an expert in nanomedicine, he has acted as evaluator (2016) and Vice-Chair (2018, 2019) for EU Horizon 2020 Future and Emerging Technologies (FET) RIA Open Calls. Dr. Gobbo’s research has been widely published, and he has had a number of publications in leading journals, most notably in Science and in Nature Communications. He has also published 1 book and 1 book chapter.
This project has received funding from the European Union’s Horizon 2020 research
and innovation programme under grant agreement No 952259.